Guggenheim Initiates Coverage On Korsana Biosciences with Buy Rating, Announces Price Target of $70
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsInitiationPrice Target
Guggenheim analyst Yatin Suneja initiates coverage on Korsana Biosciences (NASDAQ:KRSA) with a Buy rating and announces Price Target of $70.
Guggenheim analyst Yatin Suneja initiates coverage on Korsana Biosciences (NASDAQ:KRSA) with a Buy rating and announces Price Target of $70.